CMPS — Compass Pathways Plc
NASDAQ · Healthcare · Medical Care Facilities
$13.20
-$0.04 (-0.34%)
Compass Pathways Plc (CMPS) is a medical care facilities company listed on NASDAQ. It is led by Kabir Kumar Nath M.A., M.B.A., based in 33 Broadwick Street, London, United Kingdom, W1F 0DQ, with about 166 employees. COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Net income was -$137.7M. CMPS currently screens at market cap $305.0M.
Use this CMPS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CMPS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CMPS SEC filings page. Lician reads the product cache first so this HTML stays unique to Compass Pathways Plc even when a live quote feed is slow.
About Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
CMPS Key Statistics
Market Cap
$305.01M
Volume
1.72M
Previous Close
$14.88
Day Range
$14.56 – $15.01
EPS
-$2.30
Revenue
$0.00
Net Income
-$155.12M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
166
CMPS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$155.12M | -$118.46M | -$91.50M | -$71.74M |
| EPS (Diluted) | -$2.30 | -$2.32 | -$2.16 | -$1.79 |
Total Assets
$213.67M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$165.08M
Operating Cash Flow
-$119.19M
Free Cash Flow
$0.00
Compass Pathways Plc Company Information
- CEO & Director
- Kabir Kumar Nath M.A., M.B.A.
- Headquarters
- 33 Broadwick Street, London, United Kingdom, W1F 0DQ
- Website
- compasspathways.com
- Phone
- 44 71 6676 6461
- IPO / Founded
- 2020-09-18
- Sector
- Healthcare
- Industry
- Medical Care Facilities